Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Maldives.
Press releases published on September 22, 2025
Infoblox Appoints Justin Kappers as Chief Information Officer to Lead Global IT, Fuel AI Adoption and Drive Business Growth
Driving global IT strategy and operations to support Infoblox’s next phase of growth Applying AI-driven processes and driving operational excellence to enhance employee experience and deliver greater customer value Bringing 20+ years of enterprise …
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its new Life Sciences Placement Program (LSPP) in …
OpenAI and NVIDIA Announce Strategic Partnership to Deploy 10 Gigawatts of NVIDIA Systems
News Strategic partnership enables OpenAI to build and deploy at least 10 gigawatts of AI data centers with NVIDIA systems representing millions of GPUs for OpenAI’s next-generation AI infrastructure. To support the partnership, NVIDIA intends to invest up …
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong …
Angelini Pharma sigla un accordo di opzione esclusiva con Sovargen per ottenere i diritti globali di sviluppo e commercializzazione di un asset innovativo nell'ambito della salute del cervello
Angelini Pharma ottiene un'opzione esclusiva per acquisire i diritti globali di sviluppo e commercializzazione al di fuori della Repubblica di Corea, della Cina, di Hong Kong, di Macao e Taiwan di SVG1051, un’innovativa molecola sperimentale in fase …
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the brain infusion of therapeutic agents …
Strolid Launches VCONIC Inc., Attracting Jabber Co-Founders to Scale Breakthrough VCON Platform
BOSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strolid, an 11-year automotive industry leader with 180 employees that has facilitated over 3.2 million customer appointments, today announced the formation of VCONIC Inc., a new venture company commercializing …
XPPen Collaborates with the World Illustration Awards, Empowering Artists to Shine on the Global Stage
LOS ANGELES, Sept. 22, 2025 (GLOBE NEWSWIRE) -- XPPen, the leading digital art innovation brand, is proud to announce its partnership with the 2025 World Illustration Awards (WIA), one of the most influential global illustration competitions. In 2025, the …
Tag-N-Trac Breakthrough Cold Chain Tracking Solution Drives Annual Cost Savings for Pharma Shipments
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Tag-N-Trac, an AI-driven IoT-enabled logistics intelligence leader, has successfully implemented its advanced tracking technology with a leading pharmaceutical and biotechnology company. This solution, …
Trust Stamp announces Registration of Identity-Related Blockchain Token
Atlanta, GA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced the registration of the TRUSTED token on the digital asset register of the State of Wyoming. TRUSTED is an ERC-20 token that was first deployed by Trust Stamp on the …
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase 2a clinical trials Clear regulatory …
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, today announced that Fierce Biotech has named it as one of 2025’s Fierce 15 biotechnology companies, designating it as one of the most innovative and promising private …
Orchid Accelerates Identity Governance by Letting Applications Speak for Themselves
AUSTIN, Texas and NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Orchid Security, the company bringing clarity and control to the complexity of enterprise identity, today announced landmark capabilities to accelerate Identity Governance and Administration ( …
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
CALABASAS, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, will be featured on Health Uncensored …
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio Inc. today announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how large-scale proteomics data can be integrated …
AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth
OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Journal for ImmunoTherapy of Cancer (JITC) has published a new peer-reviewed article providing evidence of a positive …
Fynor × Maivest Announce Strategic Partnership to Jointly Build a Next-Generation Digital Asset Ecosystem
New York, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- As the global digital finance industry enters a new stage, two fully licensed and compliant international platforms — Fynor Global Exchange Ltd. and Maivest Digital Capital Inc. — have officially announced a …
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care and novel immunotherapies Recent financing provides extended runway through key anticipated regulatory …